Caribou Bioscience, Inc (CRBU) Prices Upsized 19M Share IPO at $16/sh
- Wall St ends higher as Fed signals bond-buying taper soon
- Fed maintains federal funds rate at 0 to 1/4; Fed maintains Treasury, MBS purchases but says moderation in pace may 'soon be warranted'
- Toast (TOST) IPO Opens Up 63%, Pushing Valuation to Nearly $33B
- Facebook (FB) Shares Hit After Warning on Impact of Apple's (AAPL) Privacy Changes
- Adobe (ADBE) Tops Q3 Estimates, After-Hours Move Lower in Shares Creates a Buying Opportunity Says Analyst
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Caribou Biosciences, Inc. (NADSAQ: CRBU) announced today the pricing of its upsized initial public offering of 19,000,000 shares of common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Caribou. The gross proceeds of the offering, before deducting underwriting discounts and commissions, and other offering expenses payable by Caribou, are expected to be $304.0 million. In addition, Caribou has granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.
The shares are expected to begin trading on the Nasdaq Global Select Market on July 23, 2021. The offering is expected to close on or about July 27, 2021, subject to the satisfaction of customary closing conditions.
BofA Securities, Citigroup, and SVB Leerink are acting as joint book-running managers for this offering.
A registration statement relating to the offering has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 22, 2021. The offering is being made only by means of a prospectus. Copies of the final prospectus relating to this offering may be obtained, when available, from: BofA Securities, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department, or by email at email@example.com; Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (800) 831-9146 or by email at firstname.lastname@example.org; or SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by telephone at (800) 808-7525, ext. 6105, or by email at email@example.com. Copies of the final prospectus, when available, related to the offering will also be accessible through the SEC’s website at www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
This press release contains statements that constitute “forward-looking statements” and include, without limitation, statements regarding Caribou’s expectations with respect to the commencement of trading of its shares on the Nasdaq Global Select Market and the size, completion and timing of the closing of the initial public offering. No assurance can be given that the offering discussed above will be completed on the terms or timing described in this release, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 7 Things to Know About the Upcoming Amplitude (AMPL) IPO
- Greenbrook TMS (GBNH) Upsizes Bought Deal Financing to $11.5M of Shares at $7.75/sh
- IPO for SPAC Inflection Point Acquisition Corp. (IPAXU) Opens at $9.81
Create E-mail Alert Related CategoriesCorporate News, IPOs
Related EntitiesCiti, IPO
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!